Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

NCT00899327 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

GENETIC: DNA methylation analysis
GENETIC: RNA analysis
GENETIC: cytogenetic analysis
GENETIC: gene expression analysis
GENETIC: mutation analysis
GENETIC: polymerase chain reaction
GENETIC: protein expression analysis
OTHER: laboratory biomarker analysis

Sponsor

Oxford University Hospitals NHS Trust